These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 19602592)
41. Expression parameters of the polycomb group proteins BMI1, SUZ12, RING1 and CBX7 in urothelial carcinoma of the bladder and their prognostic relevance. Hinz S; Kempkensteffen C; Christoph F; Krause H; Schrader M; Schostak M; Miller K; Weikert S Tumour Biol; 2008; 29(5):323-9. PubMed ID: 18984978 [TBL] [Abstract][Full Text] [Related]
42. Mechanisms of polycomb gene silencing: knowns and unknowns. Simon JA; Kingston RE Nat Rev Mol Cell Biol; 2009 Oct; 10(10):697-708. PubMed ID: 19738629 [TBL] [Abstract][Full Text] [Related]
43. CBX7 regulates stem cell-like properties of gastric cancer cells via p16 and AKT-NF-κB-miR-21 pathways. Ni SJ; Zhao LQ; Wang XF; Wu ZH; Hua RX; Wan CH; Zhang JY; Zhang XW; Huang MZ; Gan L; Sun HL; Dimri GP; Guo WJ J Hematol Oncol; 2018 Feb; 11(1):17. PubMed ID: 29422082 [TBL] [Abstract][Full Text] [Related]
44. CBX7 is a tumor suppressor in mice and humans. Forzati F; Federico A; Pallante P; Abbate A; Esposito F; Malapelle U; Sepe R; Palma G; Troncone G; Scarfò M; Arra C; Fedele M; Fusco A J Clin Invest; 2012 Feb; 122(2):612-23. PubMed ID: 22214847 [TBL] [Abstract][Full Text] [Related]
45. A multifactorial signature of DNA sequence and polycomb binding predicts aberrant CpG island methylation. McCabe MT; Lee EK; Vertino PM Cancer Res; 2009 Jan; 69(1):282-91. PubMed ID: 19118013 [TBL] [Abstract][Full Text] [Related]
46. Anti-tumoral effect of the non-nucleoside DNMT inhibitor RG108 in human prostate cancer cells. Graça I; Sousa EJ; Baptista T; Almeida M; Ramalho-Carvalho J; Palmeira C; Henrique R; Jerónimo C Curr Pharm Des; 2014; 20(11):1803-11. PubMed ID: 23888969 [TBL] [Abstract][Full Text] [Related]
48. A Noncanonical Function of Polycomb Repressive Complexes Promotes Human Cytomegalovirus Lytic DNA Replication and Serves as a Novel Cellular Target for Antiviral Intervention. Svrlanska A; Reichel A; Schilling EM; Scherer M; Stamminger T; Reuter N J Virol; 2019 May; 93(9):. PubMed ID: 30814291 [TBL] [Abstract][Full Text] [Related]
49. CBX7 and miR-9 are part of an autoregulatory loop controlling p16(INK) (4a). O'Loghlen A; Brookes S; Martin N; Rapisarda V; Peters G; Gil J Aging Cell; 2015 Dec; 14(6):1113-21. PubMed ID: 26416703 [TBL] [Abstract][Full Text] [Related]
50. Aberrant DNA hypermethylation patterns lead to transcriptional silencing of tumor suppressor genes in UVB-exposed skin and UVB-induced skin tumors of mice. Nandakumar V; Vaid M; Tollefsbol TO; Katiyar SK Carcinogenesis; 2011 Apr; 32(4):597-604. PubMed ID: 21186298 [TBL] [Abstract][Full Text] [Related]
51. Arsenic trioxide inhibits DNA methyltransferase and restores methylation-silenced genes in human liver cancer cells. Cui X; Wakai T; Shirai Y; Yokoyama N; Hatakeyama K; Hirano S Hum Pathol; 2006 Mar; 37(3):298-311. PubMed ID: 16613325 [TBL] [Abstract][Full Text] [Related]
52. Epigenetic silencing of the RASSF1A tumor suppressor gene through HOXB3-mediated induction of DNMT3B expression. Palakurthy RK; Wajapeyee N; Santra MK; Gazin C; Lin L; Gobeil S; Green MR Mol Cell; 2009 Oct; 36(2):219-30. PubMed ID: 19854132 [TBL] [Abstract][Full Text] [Related]
53. Expression of ANRIL-Polycomb Complexes-CDKN2A/B/ARF Genes in Breast Tumors: Identification of a Two-Gene (EZH2/CBX7) Signature with Independent Prognostic Value. Meseure D; Vacher S; Alsibai KD; Nicolas A; Chemlali W; Caly M; Lidereau R; Pasmant E; Callens C; Bieche I Mol Cancer Res; 2016 Jul; 14(7):623-33. PubMed ID: 27102007 [TBL] [Abstract][Full Text] [Related]
54. DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines. Roll JD; Rivenbark AG; Jones WD; Coleman WB Mol Cancer; 2008 Jan; 7():15. PubMed ID: 18221536 [TBL] [Abstract][Full Text] [Related]
55. A Non-canonical BCOR-PRC1.1 Complex Represses Differentiation Programs in Human ESCs. Wang Z; Gearhart MD; Lee YW; Kumar I; Ramazanov B; Zhang Y; Hernandez C; Lu AY; Neuenkirchen N; Deng J; Jin J; Kluger Y; Neubert TA; Bardwell VJ; Ivanova NB Cell Stem Cell; 2018 Feb; 22(2):235-251.e9. PubMed ID: 29337181 [TBL] [Abstract][Full Text] [Related]
56. A human Polycomb isoform lacking the Pc box does not participate to PRC1 complexes but forms protein assemblies and represses transcription. Völkel P; Le Faou P; Vandamme J; Pira D; Angrand PO Epigenetics; 2012 May; 7(5):482-91. PubMed ID: 22419124 [TBL] [Abstract][Full Text] [Related]
57. Polycomb complexes act redundantly to repress genomic repeats and genes. Leeb M; Pasini D; Novatchkova M; Jaritz M; Helin K; Wutz A Genes Dev; 2010 Feb; 24(3):265-76. PubMed ID: 20123906 [TBL] [Abstract][Full Text] [Related]
58. Tumor suppressor p16INK4A regulates polycomb-mediated DNA hypermethylation in human mammary epithelial cells. Reynolds PA; Sigaroudinia M; Zardo G; Wilson MB; Benton GM; Miller CJ; Hong C; Fridlyand J; Costello JF; Tlsty TD J Biol Chem; 2006 Aug; 281(34):24790-802. PubMed ID: 16766534 [TBL] [Abstract][Full Text] [Related]
59. DNMT3A R882 mutants interact with polycomb proteins to block haematopoietic stem and leukaemic cell differentiation. Koya J; Kataoka K; Sato T; Bando M; Kato Y; Tsuruta-Kishino T; Kobayashi H; Narukawa K; Miyoshi H; Shirahige K; Kurokawa M Nat Commun; 2016 Mar; 7():10924. PubMed ID: 27010239 [TBL] [Abstract][Full Text] [Related]
60. Daxx represses RelB target promoters via DNA methyltransferase recruitment and DNA hypermethylation. Puto LA; Reed JC Genes Dev; 2008 Apr; 22(8):998-1010. PubMed ID: 18413714 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]